Rocket Capital
Venture capitalAmsterdam · Series B–Late Stage · 9 people tracked
Investment thesis
Rocket Capital prioritizes long-term value creation and capital preservation through aligned incentives with investors. The firm emphasizes transparent communication and consistent reporting of capital deployment and investment performance. With regional expertise across Asia, the platform sources proprietary investment opportunities in sectors where the firm maintains strong conviction and disciplined execution capability.
Source: firm website, verified Jul 21, 2026.
Team · 9 people
from the firm's websiteFrequently asked questions
- What stage does Rocket Capital invest at?
- Rocket Capital invests at the Series B, Series C, Growth, Late Stage stages.
- What sectors does Rocket Capital focus on?
- Rocket Capital focuses on AI & Machine Learning, Enterprise Software, Healthtech, Sector Agnostic.
- Where is Rocket Capital located?
- Rocket Capital is headquartered in Amsterdam, NL.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Summit Partners is a growth-focused investment firm with over 41 years of experience investing in category-leading companies across technology, healthcare and life sciences, and growth products and services. The firm leverages a collaborative approach to support market leaders through both minority and majority investments.